Kura Oncology, Inc.
KURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422143
In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Kura Oncology, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 185
- +7 vs. Q3 2024
- Shares held
- 78.8M
- −3.56M (−4.3%) vs. Q3 2024
- Total value
- $686.3M
- −$920.7M (−57.3%) vs. Q3 2024
- New holders
- 48
- 70 more added
- Sold out
- 41
- 36 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 221 | $953.1M |
| Q1 2026 | 222 | $686.5M |
| Q4 2025 | 215 | $888.2M |
| Q3 2025 | 200 | $742.6M |
| Q2 2025 | 182 | $473.6M |
| Q1 2025 | 183 | $530.9M |
| Q4 2024 | 185 | $686.3M |
| Q3 2024 | 179 | $1.61B |
| Q2 2024 | 174 | $1.66B |
| Q1 2024 | 165 | $1.72B |
| Q4 2023 | 141 | $1.13B |
| Q3 2023 | 133 | $686.9M |
| Q2 2023 | 148 | $795.1M |
| Q1 2023 | 141 | $885.3M |
| Q4 2022 | 142 | $870.3M |
| Q3 2022 | 148 | $977.5M |
| Q2 2022 | 148 | $1.26B |
| Q1 2022 | 152 | $1.06B |
| Q4 2021 | 151 | $897.8M |
| Q3 2021 | 152 | $1.25B |
| Q2 2021 | 171 | $1.41B |
| Q1 2021 | 171 | $1.94B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Kura Oncology, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −45,927−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −44,007−100.0% | Sold out |
| Options Solutions, LLC | 0 | $0 | 0.00% | −42,726−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −37,302−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −31,654−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −30,508−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −29,655−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −26,667−100.0% | Sold out |
| Knott David M Jr | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −13,720−100.0% | Sold out |
| Erste Asset Management GmbH | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −10,831−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −7,483−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −3,700−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Jaffetilchin Investment Partners, LLC | 0 | $0 | 0.00% | −350−100.0% | Sold out |
| Ashton Thomas Securities, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −139−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −147−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Carmichael Hill & Associates, Inc. | – | – | – | – | Not filed |